Atorvastatin vs Simvastatin

Atorvastatin is a more potent statin than simvastatin. At comparable doses, atorvastatin achieves greater LDL-C reductions. For example, atorvastatin 10 mg reduces LDL-C by approximately 39%, while simvastatin 10 mg reduces it by about 30%. At maximum doses, atorvastatin 80 mg can lower LDL-C by roughly 55-60%, compared to about 47% for simvastatin 80 mg (though simvastatin 80 mg is rarely used due to myopathy risk).

The STELLAR trial (2003) directly compared statins across dose ranges and confirmed atorvastatin achieved significantly greater LDL-C reductions at every comparable dose. Both drugs effectively reduce cardiovascular events, and the 4S and CARDS trials demonstrated significant reductions in major cardiac events for simvastatin and atorvastatin, respectively.

For patients requiring aggressive LDL lowering (>50%), atorvastatin or rosuvastatin are generally preferred over simvastatin.

Both atorvastatin and simvastatin share the common statin side effect profile: muscle pain (myalgia), elevated liver enzymes, digestive issues, and headache. The overall incidence of side effects is similar between the two.

Simvastatin carries a higher risk of myopathy (serious muscle damage) at the 80 mg dose, which led the FDA in 2011 to recommend against initiating patients on simvastatin 80 mg. This restriction does not apply to atorvastatin.

Simvastatin is metabolized primarily by CYP3A4 and has more significant drug interactions — particularly with strong CYP3A4 inhibitors like clarithromycin, itraconazole, and certain HIV protease inhibitors, which can dramatically increase simvastatin levels and myopathy risk. Atorvastatin is also metabolized by CYP3A4 but is less susceptible to these interactions at standard doses.

Both atorvastatin and simvastatin are available as low-cost generics. Simvastatin has been generic since 2006, and atorvastatin since 2011. Typical retail prices for a 30-day supply of either drug range from $4 to $15 at most pharmacies, often available through discount generic programs.

Cost differences between the two are generally negligible, and both are covered by virtually all insurance formularies. Neither drug has a meaningful cost advantage over the other for most patients.

Both drugs are taken once daily as oral tablets. Simvastatin is recommended to be taken in the evening because cholesterol synthesis peaks at night and simvastatin has a shorter half-life (2-3 hours). Atorvastatin has a longer half-life (14 hours for the parent compound, 20-30 hours including active metabolites), so it can be taken at any time of day.

Neither drug requires administration with food, though simvastatin absorption is slightly increased with an evening meal. The flexibility of atorvastatin dosing timing may improve adherence for some patients.

Both atorvastatin and simvastatin are effective, well-established statins. Atorvastatin may be preferred when greater LDL reduction is needed, when dosing flexibility matters, or when fewer drug interaction concerns are desired. Simvastatin remains an excellent choice for patients who tolerate it well, particularly those requiring moderate LDL reductions.

The choice between these medications should be based on your target LDL-C level, other medications you take, and your healthcare provider's assessment of your cardiovascular risk. Consult your healthcare provider before making any changes to your medication.